T5	Pharmacological_substance 1519 1523	drug
T12	Disorder 695 698	IPF
T17	Disorder 2245 2252	disease
T24	Subject 994 1002	patients
T26	Artificial_process 1747 1762	supportive care
T27	Pharmacological_substance 1315 1326	pirfenidone
T28	Subject 1772 1780	patients
T32	Anatomical_entity 678 682	lung
T35	Pathway 619 627	pathways
T37	Method_cue 1207 1218	lung biopsy
T39	Pharmacological_substance 1300 1310	nintedanib
T44	Anatomical_entity 198 204	tissue
T56	Disorder 2339 2342	IPF
T58	Disorder 0 29	Idiopathic pulmonary fibrosis
T64	Disorder 104 107	IPF
T68	Disorder 371 374	IPF
T72	Subject 442 450	patients
T96	Subject 1791 1797	carers
T109	Disorder 2007 2010	IPF
T118	Disorder 73 102	Idiopathic pulmonary fibrosis
T124	Artificial_process 1552 1561	treatment
T126	Anatomical_entity 212 228	lungs parenchyma
T127	Subject 928 932	team
T129	Subject 1287 1295	patients
E4	Artificial_process:T26 Theme:T28
E6	Pathway:T35 
E18	Artificial_process:T124 
N13	Reference T5 UMLS:C0013227	Pharmaceutical Preparations
N33	Reference T12 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N50	Reference T17 UMLS:C0012634	Disease
N78	Reference T24 UMLS:C0030705	Patients
N83	Reference E4 UMLS:C0344211	Supportive care
N85	Reference T27 UMLS:C0298067	pirfenidone
N87	Reference T28 UMLS:C0030705	Patients
N100	Reference T32 UMLS:C0024109	Lung
N113	Reference T37 UMLS:C0189485	Biopsy of lung
N118	Reference T39 UMLS:C2930789	nintedanib
N130	Reference T44 UMLS:C0040300	Body tissue
N170	Reference T56 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N177	Reference T58 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N193	Reference T64 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N208	Reference T68 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N217	Reference T72 UMLS:C0030705	Patients
N349	Reference T109 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N402	Reference T118 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N430	Reference E18 UMLS:C0087111	Therapeutic procedure
N438	Reference T126 UMLS:C0819757	Structure of parenchyma of lung
N441	Reference T127 UMLS:C0871489	teams
N444	Reference T129 UMLS:C0030705	Patients
T130	Method_cue 1163 1203	high-resolution computed tomography scan
N1	Reference T130 UMLS:C1512457	High Resolution Computed Tomography
T91	Pharmacological_substance 1472 1477	drugs
N4	Reference T91 UMLS:C0013227	Pharmaceutical Preparations
N8	Reference T96 UMLS:C0085537	Caregiver
T3	Subject 889 900	individuals
N12	Reference E6 UMLS:C1706062	Metabolic Networks
N10	Reference T3 UMLS:C0027361	Persons
T11	Positive_regulation 748 758	activation
E2	Positive_regulation:T11 Theme:T51
N14	Reference E2 UMLS:C1879547	Activation action
T48	Positive_regulation 787 794	trigger
E10	Positive_regulation:T48 Cause:E2 Theme:E26 Cue:T43
N16	Reference E10 UMLS:C1879547	Activation action
T49	Negative_regulation 1350 1356	reduce
E11	Negative_regulation:T49 Cause:T39 Theme:E24 Cue:T73
N18	Reference E11 UMLS:C3463820	Inhibition
T10	Biological_process 31 43	pathogenesis
E12	Biological_process:T10 
N20	Reference E12 UMLS:C0699748	Pathogenesis
T30	Biological_process 375 387	pathogenesis
E16	Biological_process:T30 Theme:T68
N21	Reference E16 UMLS:C0699748	Pathogenesis
T18	Localization 173 185	accumulation
E19	Localization:T18 toLoc:T126 Theme:T44
N26	Reference E19 UMLS:C4055506	Accumulation
T47	Biological_process 1388 1404	fibrotic process
E8	Biological_process:T47 
E22	Negative_regulation:T49 Cause:T27 Theme:E24 Cue:T73
N28	Reference E22 UMLS:C3463820	Inhibition
T38	Biological_process 659 670	progression
E23	Biological_process:T38 Theme:E14
N29	Reference E23 UMLS:C0242656	Disease Progression
T65	Biological_process 1369 1380	progression
E24	Biological_process:T65 Theme:E8
N30	Reference E24 UMLS:C0242656	Disease Progression
T1	Biological_process 683 691	scarring
E14	Biological_process:T1 disorder:T12 Theme:T32
N2	Reference E14 UMLS:C0008767	Cicatrization
T23	Cellular_process 737 743	injury
E9	Cellular_process:T23 Theme:T51
N22	Reference E9 UMLS:C0599732	cell injury
T22	Biological_process 882 888	ageing
E20	Biological_process:T22 Theme:T3
N3	Reference E20 UMLS:C0001811	Aging
T40	Correlation 143 156	characterized
E21	Correlation:T40 Theme:T118 Theme2:E19
N7	Reference E21 UMLS:C0332281	Associated with
T45	Biological_process 827 844	disordered repair
E26	Biological_process:T45 atLoc:T3
N32	Reference E26 UMLS:C0151692	Impaired wound healing
T51	Cell 711 730	alveolar epithelial
N34	Reference T51 UMLS:C0225698	Alveolar Epithelial Cells
T42	Artificial_process 2313 2335	personalized treatment
E25	Artificial_process:T42 disorder:T56
N31	Reference E25 UMLS:C2718059	Precision Medicine
T31	Artificial_process 1594 1612	combined treatment
E17	Artificial_process:T31 
N36	Reference E17 UMLS:C1521750	Combination Chemotherapy
T36	Artificial_process 2226 2235	diagnosis
E7	Artificial_process:T36 Theme:T29
N37	Reference E7 UMLS:C0011900	Diagnosis
T29	Disorder 2339 2342	IPF
N42	Reference T29 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
T61	Disorder 114 121;135 142	chronic disease
N44	Reference T61 UMLS:C0008679	Chronic disease
T66	Disorder 114 142	chronic, progressive disease
N45	Reference T66 UMLS:C0008679	Chronic disease
T59	Entity_Property 123 134	progressive
N43	Reference T59 UMLS:C0205329	Progressive
R2	member_of Arg1:T66 Arg2:T61	
T67	Biological_process 643 654	development
E1	Biological_process:T67 Theme:E14
N46	Reference E1 UMLS:C0699748	Pathogenesis
T70	Molecular_function 2066 2079	gene variants
E3	Molecular_function:T70 
N47	Reference E3 UMLS:C0026882	Mutation
T25	Molecular_function 2081 2103	epigenetic alterations
E5	Molecular_function:T25 
N25	Reference E5 UMLS:C1516924	Epigenetic Process
T55	Biological_process 608 618	pathogenic
E13	Biological_process:T55 Cause:E6
T43	Speculation_cue 768 778	recognised
A1	Speculated E10
T73	Speculation_cue 1340 1346	proved
A2	Speculated E11
A3	Speculated E22
T74	Biological_process 2011 2023	pathobiology
E15	Biological_process:T74 Cause:T109
N48	Reference E15 UMLS:C0277785	Functional disorder
N9	Reference E8 UMLS:C0596570	fibrogenesis
R3	member_of Arg1:T118 Arg2:T66	
N15	Reference E13 UMLS:C0699748	Pathogenesis
